Skip to main content
. 2016 Jul 26;87(4):365–374. doi: 10.1212/WNL.0000000000002887

Figure 1. Disposition of respondents by disease-modifying therapy (DMT) use and insurance challenges.

Figure 1

(A) Cohort disposition. (B) Distribution of respondents who took DMTs through insurance coverage by experienced insurance challenges. Total of the respondents (%) in (B) is greater than 100% due to overlap in the different types of challenges.